Rapport Therapeutics (RAPP) Short Interest
Nasdaq • RAPP • US75383L1026
As of Oct 26, 2026, ORTEX estimated 7.1% of free float sold short, 3.4 days to cover, cost to borrow 0.42%. Sign up for live short interest data.
Nasdaq • RAPP • US75383L1026
As of Oct 26, 2026, ORTEX estimated 7.1% of free float sold short, 3.4 days to cover, cost to borrow 0.42%. Sign up for live short interest data.
This page tracks how heavily Rapport Therapeutics (Nasdaq:RAPP) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Rapport Therapeutics (Nasdaq: RAPP) has a market capitalization of $1.54B. Last close $25.96 (as of 2026-11-11); 52-week range $22.06 to $52.93. ORTEX data as of 2026-10-26: short interest was 7.1% of free float, 3.4 days to cover and the average cost to borrow was 0.42%. Sign up for live short interest data.